Current indications and efficacy of radiofrequency ablation in the treatment of liver cancer
ZHANG Jie
CHEN Min-shan
Abstract：Radiofrequency ablation (RFA) has been accepted as one of the curative therapies for small liver cancer, following liver resection and transplantation with its development and clinical application in liver cancer over 20 years. The published experts’ statement in China has confirmed the impartment role of RFA in the treatment of liver cancer and defined that RFA can be used as a curative treatment for single tumor ≤5 cm or tumor number ≤3 and each ≤3 cm, and as a palliative or combined treatment for unresectable single tumor >5 cm or multiple tumors >3 cm. Laparoscopic RFA is superior to percutaneous RFA for tumors in unfavorable location. RFA combined with disconnection is an effective treatment for patients with liver cancer and portal hypertension. Combined with transcatheter arterial chemoembolization (TACE), RFA can improve its ablative region, complete ablation rate and prognosis.
Keywords：liver cancerradiofrequency ablationtranscathe-ter arterial chemoembolization (TACE)
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：2( 711-712 )